BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 32353393)

  • 1. Effects of chronic nicotine exposure on Δ
    Miladinovic T; Manwell LA; Raaphorst E; Malecki SL; Rana SA; Mallet PE
    Pharmacol Biochem Behav; 2020 Jul; 194():172931. PubMed ID: 32353393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic nicotine exposure attenuates the effects of Δ
    Manwell LA; Miladinovic T; Raaphorst E; Rana S; Malecki S; Mallet PE
    Brain Behav; 2019 Nov; 9(11):e01375. PubMed ID: 31583843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repeated exposure to Delta(9)-tetrahydrocannabinol alters heroin-induced locomotor sensitisation and Fos-immunoreactivity.
    Singh ME; McGregor IS; Mallet PE
    Neuropharmacology; 2005 Dec; 49(8):1189-200. PubMed ID: 16137723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic nicotine alters cannabinoid-mediated locomotor activity and receptor density in periadolescent but not adult male rats.
    Werling LL; Reed SC; Wade D; Izenwasser S
    Int J Dev Neurosci; 2009 May; 27(3):263-9. PubMed ID: 19167478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioural and biochemical evidence for interactions between Delta 9-tetrahydrocannabinol and nicotine.
    Valjent E; Mitchell JM; Besson MJ; Caboche J; Maldonado R
    Br J Pharmacol; 2002 Jan; 135(2):564-78. PubMed ID: 11815392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional differences in naloxone modulation of Delta(9)-THC induced Fos expression in rat brain.
    Allen KV; McGregor IS; Hunt GE; Singh ME; Mallet PE
    Neuropharmacology; 2003 Feb; 44(2):264-74. PubMed ID: 12623225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre-conception exposure to THC fails to impact nicotine reward in adult offspring.
    Hempel BJ; Melkumyan M; Crissman ME; Winston CA; Madar J; Riley AL
    Pharmacol Biochem Behav; 2020 Oct; 197():173001. PubMed ID: 32710886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nicotine pre-exposure does not potentiate the locomotor or rewarding effects of Delta-9-tetrahydrocannabinol in rats.
    Le Foll B; Wiggins M; Goldberg SR
    Behav Pharmacol; 2006 Mar; 17(2):195-9. PubMed ID: 16495727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acetaldehyde, a major constituent of tobacco smoke, enhances behavioral, endocrine, and neuronal responses to nicotine in adolescent and adult rats.
    Cao J; Belluzzi JD; Loughlin SE; Keyler DE; Pentel PR; Leslie FM
    Neuropsychopharmacology; 2007 Sep; 32(9):2025-35. PubMed ID: 17287824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of delta 9-THC and anandamide induced c-fos expression in the rat forebrain.
    McGregor IS; Arnold JC; Weber MF; Topple AN; Hunt GE
    Brain Res; 1998 Aug; 802(1-2):19-26. PubMed ID: 9748483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perinatal exposure to delta(9)-tetrahydrocannabinol alters heroin-induced place conditioning and fos-immunoreactivity.
    Singh ME; McGregor IS; Mallet PE
    Neuropsychopharmacology; 2006 Jan; 31(1):58-69. PubMed ID: 15920503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Δ
    Moore CF; Davis CM; Sempio C; Klawitter J; Christians U; Weerts EM
    Cannabis Cannabinoid Res; 2024 Feb; 9(1):111-120. PubMed ID: 36179013
    [No Abstract]   [Full Text] [Related]  

  • 13. Increased sensitivity to Δ
    Ponzoni L; Moretti M; Braida D; Zoli M; Clementi F; Viani P; Sala M; Gotti C
    Eur Neuropsychopharmacol; 2019 Apr; 29(4):566-576. PubMed ID: 30773388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delta9-tetrahydrocannabinol decreases somatic and motivational manifestations of nicotine withdrawal in mice.
    Balerio GN; Aso E; Berrendero F; Murtra P; Maldonado R
    Eur J Neurosci; 2004 Nov; 20(10):2737-48. PubMed ID: 15548217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nicotinic facilitation of delta9-tetrahydrocannabinol discrimination involves endogenous anandamide.
    Solinas M; Scherma M; Tanda G; Wertheim CE; Fratta W; Goldberg SR
    J Pharmacol Exp Ther; 2007 Jun; 321(3):1127-34. PubMed ID: 17351107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Dopamine Type 1 Receptors and Dopamine- and cAMP-Regulated Phosphoprotein Mr 32 kDa in Δ9-Tetrahydrocannabinol-Mediated Induction of ΔFosB in the Mouse Forebrain.
    Lazenka MF; Tomarchio AJ; Lichtman AH; Greengard P; Flajolet M; Selley DE; Sim-Selley LJ
    J Pharmacol Exp Ther; 2015 Sep; 354(3):316-27. PubMed ID: 26099530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neural correlates of interactions between cannabidiol and Δ(9) -tetrahydrocannabinol in mice: implications for medical cannabis.
    Todd SM; Arnold JC
    Br J Pharmacol; 2016 Jan; 173(1):53-65. PubMed ID: 26377899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Locomotor activity to nicotine and Fos immunoreactivity in the paraventricular nucleus of the hypothalamus in adolescent socially-stressed rats.
    McCormick CM; Ibrahim FN
    Pharmacol Biochem Behav; 2007 Jan; 86(1):92-102. PubMed ID: 17270257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delta9-tetrahydrocannabinol increases sequence-specific AP-1 DNA-binding activity and Fos-related antigens in the rat brain.
    Porcella A; Gessa GL; Pani L
    Eur J Neurosci; 1998 May; 10(5):1743-51. PubMed ID: 9751146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prior exposure to THC increases the addictive effects of nicotine in rats.
    Panlilio LV; Zanettini C; Barnes C; Solinas M; Goldberg SR
    Neuropsychopharmacology; 2013 Jun; 38(7):1198-208. PubMed ID: 23314220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.